<SEC-DOCUMENT>0000950103-25-013072.txt : 20251010
<SEC-HEADER>0000950103-25-013072.hdr.sgml : 20251010
<ACCEPTANCE-DATETIME>20251010125347
ACCESSION NUMBER:		0000950103-25-013072
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20251010
DATE AS OF CHANGE:		20251010

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251387136

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp235725_424b2-7895ms.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.5pt 0pt 0; color: red"><B>The information in this preliminary pricing
    supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus and prospectus supplement
    do not constitute an offer to sell the securities and we are not soliciting an offer to buy the securities in any state where the offer
    or sale is not permitted.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.5pt 0pt 0; color: red"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.5pt 0pt 0; text-align: center; color: red"><B>Subject to Completion.
Dated October 10, 2025</B>&nbsp;</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: gray"><B><IMG SRC="image_004.jpg" ALT="" STYLE="height: 46px; width: 183px"></B></FONT></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.5pt 0pt 0; text-align: right">October 2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.5pt 0pt 0; text-align: right">Registration Statement No. 333-287303</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.5pt 0pt 0; text-align: right">Pricing Supplement dated October&nbsp;&nbsp;&nbsp;&nbsp;,
2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.5pt 0pt 0; text-align: right">Filed pursuant to Rule 424(b)(2)</P></TD></TR>
  </TABLE>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><FONT STYLE="text-transform: uppercase">Structured Investments</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Opportunities in U.S. Equities</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Contingent Income Auto-Callable Securities due October
22, 2026</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: gray"><B>Based on the Performance of the
Common Stock of Pfizer Inc.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: gray"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: gray"><B>Principal at Risk Securities</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: gray"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Unlike conventional debt securities, the securities do not guarantee
the payment of interest or the return of the full principal amount at maturity. Instead, the securities offer the opportunity for investors
to receive a contingent quarterly payment equal to at least 2.7125% of the stated principal amount (the actual contingent quarterly payment
will be determined on the pricing date) with respect to each quarterly determination date on which the closing price of the underlier
is greater than or equal to 75% of the initial underlier value, which we refer to as the downside threshold level. If the closing price
of the underlier is greater than or equal to the initial underlier value on any determination date (other than the final determination
date), the securities will be automatically redeemed for an amount per security equal to the stated principal amount <I>plus</I> the contingent
quarterly payment otherwise due. However, if on any determination date the closing price of the underlier is less than the initial underlier
value, the securities will not be redeemed and if that closing price is less than the downside threshold level, investors will not receive
any contingent quarterly payment for the related quarterly period. If the securities are not redeemed prior to maturity and the final
underlier value is greater than or equal to the downside threshold level, the payment at maturity due on the securities will be equal
to the stated principal amount <I>plus</I> the contingent quarterly payment otherwise due. However, if the securities are not redeemed
prior to maturity and the final underlier value is less than the downside threshold level, at maturity investors will lose 1% of the stated
principal amount for every 1% that the final underlier value is less than the initial underlier value. Under these circumstances, the
amount investors receive will be less than 75% of the stated principal amount and could be zero. The securities are for investors who
are willing and able to risk their principal and forgo guaranteed interest payments, in exchange for the opportunity to potentially receive
contingent quarterly payments at an above-market rate, subject to automatic early redemption. Investors will not participate in any appreciation
of the underlier even though investors will be exposed to the depreciation in the value of the underlier if the securities have not been
redeemed prior to maturity and the final underlier value is less than the downside threshold level. <B>Investors may lose their entire
initial investment in the securities. The securities are unsecured and unsubordinated debt obligations of Barclays Bank PLC. Any payment
on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed
by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in
Power (as described on page 5 of this document) by the relevant U.K. resolution authority, you might not receive any amounts owed to you
under the securities. See &ldquo;Risk Factors&rdquo; and &ldquo;Consent to U.K. Bail-in Power&rdquo; in this document and &ldquo;Risk
Factors&rdquo; in the accompanying prospectus supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #296DC1">
    <TD STYLE="width: 20%; border-top: #4F81BD 1pt solid; border-left: #4F81BD 1pt solid; font-size: 10pt; color: white; font-weight: bold"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">SUMMARY TERMS*</FONT></TD>
    <TD STYLE="width: 80%; border-top: #4F81BD 1pt solid; border-right: #4F81BD 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Issuer:</FONT></TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Reference asset:</FONT></TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">Pfizer Inc. common stock (Bloomberg ticker symbol &ldquo;PFE UN&lt;Equity&gt;&rdquo;) (the &ldquo;underlier&rdquo;)</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Aggregate principal amount:</FONT></TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Stated principal amount:</FONT></TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Pricing date<SUP>&dagger;</SUP>:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">October 17, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Original issue date:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">October 22, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Maturity date<SUP>&dagger;</SUP>:</FONT></TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">October 22, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Automatic early redemption:</FONT></TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">If, on any determination date (other than the final determination date), the closing price of the underlier is greater than or equal to the initial underlier value, the securities will be automatically redeemed for an early redemption payment on the contingent payment date immediately following that determination date. <B>The securities will not be redeemed early if the closing price of the underlier is less than the initial underlier value on the related determination date. No further payments will be made on the securities after they have been redeemed.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Early redemption payment:</FONT></TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">The early redemption payment will be an amount per security equal to (i) the stated principal amount <I>plus</I> (ii) the contingent quarterly payment otherwise due.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Contingent quarterly payment:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2pt 0pt 14.65pt; text-indent: -9pt"><FONT STYLE="font-family: Symbol">&middot;&nbsp;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If,
    on any determination date, the closing price of the underlier is <B>greater than or equal to</B> the downside threshold level, we will
    pay a contingent quarterly payment of at least $27.125 (at least 2.7125% of the stated principal amount) per security on the related contingent
    payment date. The actual contingent quarterly payment will be determined on the pricing date.</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2pt 0pt 14.65pt; text-indent: -9pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2pt 0pt 14.65pt; text-indent: -9pt"><FONT STYLE="font-family: Symbol">&middot;&nbsp;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If,
    on any determination date, the closing price of the underlier is <B>less than</B> the downside threshold level, no contingent quarterly
    payment will be made with respect to that determination date. </FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2pt 0pt 14.65pt; text-indent: -9pt"></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Payment at maturity:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not redeemed prior to maturity, you will receive
    on the maturity date a cash payment per security determined as follows:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2pt 0pt 14.65pt; text-indent: -9pt"><FONT STYLE="font-family: Symbol">&middot;&nbsp;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If
    the final underlier value is <B>greater than or equal to</B> the downside threshold level: </FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2pt 0pt 14.65pt; text-indent: -9pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0in">(i) stated principal amount <I>plus</I>
(ii) the contingent quarterly payment otherwise due&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2pt 0pt 14.65pt; text-indent: -9pt"><FONT STYLE="font-family: Symbol">&middot;&nbsp;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If
    the final underlier value is <B>less than</B> the downside threshold level:</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2pt 0pt 14.65pt; text-indent: -9pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0in">stated principal amount &times; underlier
    performance factor</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Under these circumstances, the payment at maturity will be less
    than the stated principal amount of $1,000 and will represent a loss of more than 25%, and possibly all, of an investor&rsquo;s initial
    investment. Investors may lose their entire initial investment in the securities. Any payment on the securities, including any repayment
    of principal, is not guaranteed by any third party and is subject to (a) the creditworthiness of Barclays Bank PLC and (b) the risk of
    exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority.</I></B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">U.K. Bail-in Power acknowledgment:</FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Notwithstanding and to the exclusion of any other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page 5 of this document.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Downside threshold level:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which is equal to 75% of the initial underlier value (rounded to two decimal places)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Initial underlier value:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which is the closing price of the underlier on the pricing date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Final underlier value:</FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The closing price of the underlier on the final determination date </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Underlier performance factor: </FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">final underlier value / initial underlier value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt"><B><I>(terms continued on the next page)</I></B></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 27%; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Commissions and initial issue price:</FONT></TD>
    <TD STYLE="width: 15%; text-align: center; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Initial issue price<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 19%; text-align: center; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Price to public<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 18%; text-align: center; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Agent&rsquo;s commissions</FONT></TD>
    <TD STYLE="width: 21%; text-align: center; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Proceeds to issuer</FONT></TD></TR>
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="padding-left: 33.05pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Per security</FONT></TD>
    <TD STYLE="text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$1,000</FONT></TD>
    <TD STYLE="text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$1,000</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$12.50<SUP>(2)</SUP>&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$5.00<SUP>(3)</SUP>&nbsp;</P></TD>
    <TD STYLE="text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$982.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 33.05pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Total</FONT></TD>
    <TD STYLE="text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">$</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>(1)</B></TD><TD><B>Our estimated value of the securities on the pricing date, based on our internal pricing models, is expected to be between $923.40
and $973.40 per security. The estimated value is expected to be less than the initial issue price of the securities. See &ldquo;Additional
Information Regarding Our Estimated Value of the Securities&rdquo; on page 4 of this document.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>(2)</B></TD><TD><B>Morgan Stanley Wealth Management and its financial advisors will collectively receive from the agent, Barclays Capital Inc., a
fixed sales commission of $12.50 for each security they sell. See &ldquo;Supplemental Plan of Distribution&rdquo; in this document.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>(3)</B></TD><TD><B>Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $5.00 for each security.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">One or more of our affiliates may purchase up to 15% of the aggregate
principal amount of the securities and hold such securities for investment for a period of at least 30 days. Accordingly, the total principal
amount of the securities may include a portion that was not purchased by investors on the original issue date. Any unsold portion held
by our affiliate(s) may affect the supply of securities available for secondary trading and, therefore, could adversely affect the price
of the securities in the secondary market. Circumstances may occur in which our interests or those of our affiliates could be in conflict
with your interests.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: red"><B>Investing in the securities involves risks not associated
with an investment in conventional debt securities. See &ldquo;Risk Factors&rdquo; beginning on page 11 of this document and beginning
on page S-9 of the prospectus supplement. You should read this document together with the related prospectus and prospectus supplement,
each of which can be accessed via the hyperlinks below, before you make an investment decision.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: red"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>The securities will not be listed on any U.S. securities exchange
or quotation system. Neither the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) nor any state securities commission has
approved or disapproved of the securities or determined that this document is truthful or complete. Any representation to the contrary
is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>The securities constitute our unsecured and unsubordinated obligations.
The securities are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial Services Compensation Scheme
or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit insurance agency of the United
States, the United Kingdom or any other jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 12pt; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Prospectus dated May 15, 2025</B></FONT></A></TD>
    <TD STYLE="width: 50%; font-size: 12pt; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Prospectus Supplement dated May 15, 2025</B></FONT></A></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: #296DC1 0.75pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="border-top: #296DC1 0.75pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt"><B><I>Terms continued from previous page:</I></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">Determination dates<SUP>&dagger;</SUP>:</FONT></TD>
    <TD STYLE="width: 80%; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">January 20, 2026, April 17, 2026, July 17, 2026 and October 19, 2026. We also refer to October 19, 2026 as the final determination date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Contingent payment dates<SUP>&dagger;</SUP>:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">January 23, 2026, April 22, 2026, July 22, 2026 and the maturity date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Closing price:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Closing price has the meaning set forth under &ldquo;Reference Assets&mdash;Equity Securities&mdash;Special Calculation Provisions&rdquo; in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Calculation agent:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Additional terms:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Terms used in this document, but not defined herein, will have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">06746EFY6 / US06746EFY68</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Listing:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The securities will not be listed on any securities exchange.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Selected dealer:</B></FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Morgan Stanley Wealth Management (&ldquo;MSWM&rdquo;)</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="width: 98%; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">The underlier and the terms of the securities are subject to adjustment by the calculation agent and the maturity date may be accelerated, in each case under certain circumstances as set forth in the accompanying prospectus supplement. See &ldquo;Risk Factors&mdash;Risks Relating to the Underlier&rdquo; below.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-size: 10pt"><SUP>&dagger;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">Subject to postponement in certain circumstances, as described under &ldquo;Reference Assets&mdash;Equity Securities&mdash;Market Disruption Events for Securities with an Equity Security as a Reference Asset&rdquo; and &ldquo;Terms of the Notes&mdash;Payment Dates&rdquo; in the accompanying prospectus supplement</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 12pt"><B>Barclays Capital Inc</B>.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Additional Terms of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read this document together with the prospectus dated May
15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term Notes, Series A, of which
the securities are a part. This document, together with the documents listed below, contains the terms of the securities and supersedes
all prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms,
correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should
carefully consider, among other things, the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement and &ldquo;Risk
Factors&rdquo; in this document, as the securities involve risks not associated with conventional debt securities. We urge you to consult
your investment, legal, tax, accounting and other advisors before you invest in the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You may access these documents on the SEC website at www.sec.gov as
follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 12pt; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Prospectus dated May 15, 2025:<BR>
</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 12pt; color: #A9C4EB">&sect;</FONT></TD><TD>Prospectus supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm" STYLE="color: Blue; text-decoration: underline">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Our SEC file number is 1-10257 and our Central Index Key, or CIK, on
the SEC website is 0000312070. As used in this document, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank
PLC.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In connection with this offering, Morgan Stanley Wealth Management is
acting in its capacity as a selected dealer.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Additional Information Regarding Our Estimated Value
of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Our internal pricing models take into account a number of variables
and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility, interest rates
and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on variables, such
as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels at which our
benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal funding rates.
Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark debt securities
trade in the secondary market.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Our estimated value of the securities on the pricing date is expected
to be less than the initial issue price of the securities. The difference between the initial issue price of the securities and our estimated
value of the securities is expected to result from several factors, including any sales commissions expected to be paid to Barclays Capital
Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated
intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the
estimated cost that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may
incur in connection with the securities. These other costs will include a fee paid to LFT Securities, LLC, an entity in which an affiliate
of Morgan Stanley Wealth Management has an ownership interest, for providing certain electronic platform services with respect to this
offering.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Our estimated value on the pricing date is not a prediction of the price
at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital Inc. may buy or sell the
securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or another affiliate of ours
intends to offer to purchase the securities in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming that all relevant factors remain constant after the pricing
date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if any, and the value
that we may initially use for customer account statements, if we provide any customer account statements at all, may exceed our estimated
value on the pricing date for a temporary period expected to be approximately 40 days after the initial issue date of the securities because,
in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under
the securities and other costs in connection with the securities that we will no longer expect to incur over the term of the securities.
We made such discretionary election and determined this temporary reimbursement period on the basis of a number of factors, which may
include the tenor of the securities and/or any agreement we may have with the distributors of the securities. The amount of our estimated
costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we
may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue date of the
securities based on changes in market conditions and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>We urge you to read &ldquo;Risk Factors&rdquo; beginning on page
11 of this document.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You may revoke your offer to purchase the securities at any time
prior to the pricing date. We reserve the right to change the terms of, or reject any offer to purchase, the securities prior to their
pricing date. In the event of any changes to the terms of the securities, we will notify you and you will be asked to accept such changes
in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Consent to U.K. Bail-in Power</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Notwithstanding and to the exclusion of any other term of the securities
or any other agreements, arrangements or understandings between us and any holder or beneficial owner of the securities (or the trustee
on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner of the securities acknowledges,
accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Under the U.K. Banking Act 2009, as amended, the relevant U.K. resolution
authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority is satisfied that the resolution
conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely to fail to satisfy the Financial
Services and Markets Act 2000 (the &ldquo;FSMA&rdquo;) threshold conditions for authorization to carry on certain regulated activities
(within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that is a European Economic Area (&ldquo;EEA&rdquo;)
or third country institution or investment firm, that the relevant EEA or third country relevant authority is satisfied that the resolution
conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The U.K. Bail-in Power includes any write-down, conversion, transfer,
modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of the principal amount
of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all, or a portion, of the principal amount
of, or interest on, or any other amounts payable on, the securities into shares or other securities or other obligations of Barclays Bank
PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the securities of such shares, securities
or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration of the maturity of the securities, or
the amendment of the amount of interest or any other amounts due on the securities, or the dates on which interest or any other amounts
become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation
of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power.
Each holder and beneficial owner of the securities further acknowledges and agrees that the rights of the holders or beneficial owners
of the securities are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by
the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders
or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority in breach of laws applicable in England.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For more information, please see &ldquo;Risk Factors&mdash;Risks Relating
to the Issuer&mdash;You may lose some or all of your investment if any U.K. bail-in power is exercised by the relevant U.K. resolution
authority&rdquo; in this document as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating to the Securities
Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail, including the exercise
by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely affect the value of
any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms of the securities,
you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo; in the accompanying
prospectus supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Investment Summary</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>Contingent Income Auto-Callable Securities </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Contingent Income Auto-Callable Securities due October 22, 2026
Based on the Performance of the Common Stock of Pfizer Inc., which we refer to as the securities, provide an opportunity for investors
to receive a contingent quarterly payment, which is an amount equal to at least $27.125 (at least 2.7125% of the stated principal amount),
with respect to each quarterly determination date on which the closing price of the underlier is greater than or equal to 75% of the initial
underlier value, which we refer to as the downside threshold level. However, if the closing price of the underlier is less than the downside
threshold level on a determination date, investors will not receive any contingent quarterly payment for that determination date. The
actual contingent quarterly payment will be determined on the pricing date. The closing price of the underlier could be below the downside
threshold level on most or all of the determination dates so that you receive few or no contingent quarterly payments over the term of
the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the closing price of the underlier is greater than or equal to the
initial underlier value on any determination date (other than the final determination date), the securities will be automatically redeemed
for an early redemption payment equal to the stated principal amount <I>plus</I> the contingent quarterly payment otherwise due. If the
securities are automatically redeemed prior to maturity, investors will receive no further contingent quarterly payments. At maturity,
if the securities have not previously been redeemed and the final underlier value is greater than or equal to the downside threshold level,
the payment at maturity will be equal to the stated principal amount <I>plus</I> the contingent quarterly payment otherwise due. However,
if the securities have not previously been redeemed and the final underlier value is less than the downside threshold level, investors
will lose 1% of the stated principal amount for every 1% that the final underlier value is less than the initial underlier value. Under
these circumstances, the amount investors receive will be less than 75% of the stated principal amount and could be zero. Investors in
the securities must be willing and able to accept the risk of losing their entire initial investment and also the risk of not receiving
any contingent quarterly payment throughout the entire term of the securities. In addition, investors will not participate in any appreciation
of the underlier.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Key Investment Rationale</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities are for investors who are willing and able to risk their
principal and forgo guaranteed interest payments, in exchange for the opportunity to potentially receive contingent quarterly payments
at an above-market rate, subject to automatic early redemption. The securities offer investors an opportunity to receive a contingent
quarterly payment of at least $27.125 (at least 2.7125% of the stated principal amount) with respect to each determination date on which
the closing price of the underlier is greater than or equal to the downside threshold level. The actual contingent quarterly payment will
be determined on the pricing date. In addition, the following scenarios reflect the potential payment on the securities, if any, upon
an automatic early redemption or at maturity:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 4pt; width: 15%; border: white 3pt solid; background-color: #DCEBF4; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Scenario 1</B></FONT></TD>
    <TD STYLE="padding: 4pt; width: 85%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>On any determination date (other than the final determination
    date), the closing price of the underlier is <I>greater than or equal to</I> the initial underlier value.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
    securities will be automatically redeemed for (i) the stated principal amount <I>plus</I> (ii) the contingent quarterly payment otherwise
    due. </FONT></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Investors
    will not participate in any appreciation of the underlier from the initial underlier value and will receive no further contingent quarterly
    payments.</FONT></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 4pt; border-right: white 3pt solid; border-bottom: white 3pt solid; border-left: white 3pt solid; background-color: #DCEBF4; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Scenario 2</B></FONT></TD>
    <TD STYLE="padding: 4pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>The securities are not automatically redeemed prior
    to maturity and the final underlier value is <I>greater than or equal to </I>the downside threshold level.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
    payment due at maturity will be (i) the stated principal amount <I>plus</I> (ii) the contingent quarterly payment otherwise due.</FONT></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Investors
    will not participate in any appreciation of the underlier from the initial underlier value.</FONT></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 4pt; border-right: white 3pt solid; border-bottom: white 3pt solid; border-left: white 3pt solid; background-color: #DCEBF4; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Scenario 3</B></FONT></TD>
    <TD STYLE="padding: 4pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>The securities are not automatically redeemed prior
    to maturity and the final underlier value is <I>less than</I> the downside threshold level.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;&#9;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
    payment due at maturity will be equal to the stated principal amount <I>times</I> the underlier performance factor. In this case, at maturity,
    the securities pay less than 75% of the stated principal amount and the percentage loss of the stated principal amount will be equal to
    the percentage decrease in the final underlier value from the initial underlier value. For example, if the final underlier value is 55%
    less than the initial underlier value, the securities will pay $450.00 per security, or 45% of the stated principal amount, for a loss
    of 55% of the stated principal amount. <B>Investors will lose a significant portion and may lose all of their principal in this scenario.</B></FONT></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Selected Purchase Considerations</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">The securities are not appropriate
for all investors. The securities <I>may</I> be an appropriate investment for you if all of the following statements are true:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You do not seek an investment that produces fixed periodic
interest or coupon payments or other non-contingent sources of current income. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You do not anticipate that the final underlier value will
be less than the downside threshold level on the final determination date, and you are willing and able to accept the risk that, if it
is, you will lose a significant portion or all of the stated principal amount. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You do not anticipate that the closing price of the underlier
will be less than the downside threshold level on any determination date, and you are willing and able to accept the risk that, if it
is, you may receive few or no contingent quarterly payments over the term of the securities. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are willing and able to forgo participation in any appreciation
of the underlier, and you understand that any return on your investment will be limited to the contingent quarterly payments that may
be payable on the securities. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are willing and able to accept the risks associated with
an investment linked to the performance of the underlier, as explained in more detail in the &ldquo;Risk Factors&rdquo; section of this
document. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You understand and accept that you will not be entitled to
receive dividends or distributions that may be paid to holders of the underlier, nor will you have any voting rights with respect to the
issuer of the underlier. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are willing and able to accept the risk that the securities
may be automatically redeemed prior to scheduled maturity and that you may not be able to reinvest your money in an alternative investment
with comparable risk and yield. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You do not seek an investment for which there will be an
active secondary market and you are willing and able to hold the securities to maturity if the securities are not automatically redeemed.
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are willing and able to assume our credit risk for all
payments on the securities. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are willing and able to consent to the exercise of any
U.K. Bail-in Power by any relevant U.K. resolution authority. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">The securities <I>may <U>not</U></I>
be an appropriate investment for you if <I>any</I> of the following statements are true:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You seek an investment that produces fixed periodic interest
or coupon payments or other non-contingent sources of current income. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You seek an investment that provides for the full repayment
of principal at maturity. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You anticipate that the final underlier value will be less
than the downside threshold level on the final determination date, or you are unwilling or unable to accept the risk that, if it is, you
will lose a significant portion or all of the stated principal amount. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You anticipate that the closing price of the underlier will
be less than the downside threshold level on one or more determination dates, or you are unwilling or unable to accept the risk that,
if it is, you may receive few or no contingent quarterly payments over the term of the securities. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You seek exposure to any upside performance of the underlier
or you seek an investment with a return that is not limited to the contingent quarterly payments that may be payable on the securities.
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are unwilling or unable to accept the risks associated
with an investment linked to the performance of the underlier, as explained in more detail in the &ldquo;Risk Factors&rdquo; section of
this document. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You seek an investment that entitles you to dividends or
distributions on, or voting rights related to, the underlier.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are unwilling or unable to accept the risk that the securities
may be automatically redeemed prior to scheduled maturity. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You seek an investment for which there will be an active
secondary market and/or you are unwilling or unable to hold the securities to maturity if they are not automatically redeemed. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are unwilling or unable to assume our credit risk for
all payments on the securities. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #DCEBF4">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You are unwilling or unable to consent to the exercise of
any U.K. Bail-in Power by any relevant U.K. resolution authority. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>You must rely on your own evaluation of the merits of an investment
in the securities</I>. </B>You should reach a decision whether to invest in the securities after carefully considering, with your advisors,
the appropriateness of the securities in light of your investment objectives and the specific information set forth in this document,
the prospectus and the prospectus supplement. Neither the issuer nor Barclays Capital Inc. makes any recommendation as to the appropriateness
of the securities for investment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">How the Securities Work</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following diagrams illustrate the potential outcomes for the securities
depending on the closing price of the underlier on the determination dates.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>Diagram #1: Determination Dates Prior to the Final
Determination Date</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;<IMG SRC="image_007.jpg" ALT=""></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>Diagram #2: Payment at Maturity If No Automatic Early
Redemption Occurs</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;<IMG SRC="image_008.jpg" ALT=""></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>For
more information about the payment upon an automatic early redemption or at maturity in different hypothetical scenarios, see &ldquo;Hypothetical
Examples&rdquo; below. </I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Hypothetical Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The numbers appearing in the following examples may have been rounded
for ease of analysis. The examples below assume that the securities will be held until maturity or earlier redemption and do not take
into account the tax consequences of an investment in the securities. The examples below are based on the following terms:*</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 98%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="padding-right: 4pt; width: 38%; font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold; padding-left: 4pt"><FONT STYLE="font-size: 10pt">Hypothetical Initial Underlier Value:</FONT></TD>
    <TD STYLE="padding-right: 4pt; width: 62%; font-size: 11pt; padding-left: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4pt; font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold; padding-left: 4pt"><FONT STYLE="font-size: 10pt">Hypothetical Downside Threshold Level:</FONT></TD>
    <TD STYLE="padding-right: 4pt; font-size: 11pt; padding-left: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$75.00, which is 75% of the hypothetical initial underlier value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="padding-right: 4pt; font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold; padding-left: 4pt"><FONT STYLE="font-size: 10pt">Hypothetical Contingent Quarterly Payment:</FONT></TD>
    <TD STYLE="padding-right: 4pt; font-size: 11pt; padding-left: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$27.125 (2.7125% of the stated principal amount). The actual contingent quarterly payment will be set on the pricing date and will be at least 2.7125% of the stated principal amount.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4pt; font-size: 10pt; text-align: left; layout-grid-mode: char; color: #296DC1; font-weight: bold; padding-left: 4pt"><FONT STYLE="font-size: 10pt">Stated Principal Amount:</FONT></TD>
    <TD STYLE="padding-right: 4pt; font-size: 11pt; padding-left: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000 per security</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Terms used for purposes of these hypothetical examples may not represent
the actual initial underlier value, downside threshold level or contingent quarterly payment applicable to the securities. In particular,
the hypothetical initial underlier value of $100.00 used in these examples has been chosen for illustrative purposes only and may not
represent a likely actual initial underlier value. Please see &ldquo;Pfizer Inc. Overview&rdquo; below for recent actual values of the
underlier. The actual initial underlier value, downside threshold level and contingent quarterly payment applicable to the securities
will be determined on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In Examples 1 and 2, the closing price of the underlier is greater than
or equal to the hypothetical initial underlier value of $100.00 on one of the determination dates prior to the final determination date
(the actual initial underlier value will be determined on the pricing date). Because the closing price of the underlier is greater than
or equal to the initial underlier value on one of the determination dates prior to the final determination date, the securities are automatically
redeemed following the relevant determination date. In Examples 3 and 4, the closing price of the underlier on the determination dates
prior to the final determination date is less than the initial underlier value, and, consequently, the securities are not automatically
redeemed prior to, and remain outstanding until, maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; border: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Example 1</B></FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Example 2</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Determination</B><BR>
<B>Dates</B></FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Hypothetical<BR>
Closing Price</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Contingent</FONT></P>
                                                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Quarterly</FONT></P>
                                                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Payment (per</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">security)</FONT></P></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Early</FONT></P>
                                                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Redemption</FONT></P>
                                                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Payment (per</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">security)</FONT></P></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Hypothetical<BR>
Closing Price</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Aria, Helvetica, Sans-Serif; font-size: 10pt">Contingent<BR> Quarterly</FONT></P>
                                                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Aria, Helvetica, Sans-Serif; font-size: 10pt">Payment </FONT>(per</P>
                                                                                                              <P STYLE="margin-top: 0; margin-bottom: 0">security)</P></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Early<BR>
Redemption<BR> Payment </FONT>(per</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">security)</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>#1</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$100.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;*</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,027.125</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$85.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$27.125</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>#2</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$50.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>#3</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$125.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;*</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,027.125</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Final Determination Date</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Payment at Maturity</B></FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* If the securities are automatically redeemed, the early redemption
payment will include the contingent quarterly payment otherwise due.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In Example 1, the securities are automatically redeemed following the
first determination date, as the closing price of the underlier on the first determination date is greater than or equal to the initial
underlier value. Following the first determination date, you receive the early redemption payment, calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">stated principal amount + contingent quarterly payment
= $1,000 + $27.125 = $1,027.125</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>In this example, the automatic early redemption feature limits the
term of your investment to approximately 3 months and you may not be able to reinvest at comparable terms or returns. If the securities
are redeemed early, you will stop receiving contingent quarterly payments.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In Example 2, the securities are automatically redeemed following the
third determination date, as the closing price of the underlier on the third determination date is greater than the initial underlier
value. As the closing price of the underlier on the first determination date is greater than or equal to the downside threshold level,
you receive the contingent quarterly payment of $27.125 with respect to that determination date. Following the third determination date,
you receive an early redemption payment of $1,027.125, which includes the contingent quarterly payment with respect to that determination
date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>In this example, the automatic early redemption feature limits the
term of your investment to approximately 9 months and you may not be able to reinvest at comparable terms or returns. If the securities
are redeemed early, you will stop receiving contingent quarterly payments. Further, although the underlier has appreciated by 25% from
the initial underlier value on the third determination date, upon automatic early redemption, you receive only $1,027.125 per security
and do not benefit from such appreciation.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; border: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Example 3</B></FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Example 4</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Determination<BR>
Dates</B></FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Hypothetical<BR>
Closing Price</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Contingent<BR>
Quarterly<BR>
Payment (per<BR>
security)</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Early<BR>
Redemption<BR>
Payment (per<BR>
security)</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Hypothetical<BR>
Closing Price</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Contingent<BR>
Quarterly<BR>
Payment (per<BR>
security)</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Early<BR>
Redemption<BR> Payment </FONT>(per</P>
                                                                                                              <P STYLE="margin-top: 0; margin-bottom: 0">security)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>#1</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$65.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$60.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>#2</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$60.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$65.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>#3</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$40.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$60.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Final Determination Date</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$50.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$85.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;*</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Payment at<BR>
Maturity</B></FONT></TD>
    <TD COLSPAN="3" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center; font-size: 10pt; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>$500.00</B></FONT></TD>
    <TD COLSPAN="3" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center; font-size: 10pt; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>$1,027.125</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* The final contingent quarterly payment, if any, will be paid at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Examples 3 and 4 illustrate the payment at maturity per security based
on the final underlier value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In Example 3, the closing price of the underlier is below the downside
threshold level on each determination date throughout the term of the securities. As a result, you do not receive any contingent quarterly
payments during the term of the securities. In addition, because the final underlier value is less than the downside threshold level,
at maturity, you are fully exposed to the decline in the closing price of the underlier. Thus, investors will receive a cash payment at
maturity that is significantly less than the stated principal amount, calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$1,000 &times; underlier performance factor&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">= $1,000 &times; (final underlier value / initial
underlier value)&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">= $1,000 &times; ($50.00 / $100.00)&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">= $500.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>In this example, the cash payment you receive at maturity is significantly
less than the stated principal amount.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In Example 4, the closing price of the underlier is below the downside
threshold level on each of the determination dates prior to the final determination date. As a result, you do not receive any contingent
quarterly payments following those determination dates. In addition, the closing price of the underlier decreases to a final underlier
value of $85.00. Although the final underlier value is less than the initial underlier value, because the final underlier value is still
not less than the downside threshold level, you receive the stated principal amount <I>plus</I> the contingent quarterly payment otherwise
due. Your payment at maturity is calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$1,000 + $27.125 = $1,027.125</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>In this example, although the final underlier value represents a
decline of 15% from the initial underlier value, you receive the stated principal amount </I>plus <I>the contingent quarterly payment
otherwise due, equal to a total payment of $1,027.125 per security at maturity.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Risk Factors</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>An investment in the securities involves significant risks. We urge
you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities. Investing in the securities
is not equivalent to investing directly in the underlier. Some of the risks that apply to an investment in the securities are summarized
below, but we urge you to read the more detailed explanation of risks relating to the securities generally in the &ldquo;Risk Factors&rdquo;
section of the prospectus supplement. You should not purchase the securities unless you understand and can bear the risks of investing
in the securities.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>Risks Relating to the Securities Generally</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The securities do not guarantee the return of any principal.</B>
The terms of the securities differ from those of ordinary debt securities in that the securities do not guarantee the return of any of
the stated principal amount at maturity. Instead, if the securities have not been automatically redeemed prior to maturity and if the
final underlier value is less than the downside threshold level, you will be exposed to the decline in the closing price of the underlier,
as compared to the initial underlier value, on a 1-to-1 basis and you will receive for each security that you hold at maturity an amount
in cash equal to the stated principal amount times the underlier performance factor. Under these circumstances, your payment at maturity
will be less than 75% of the stated principal amount and could be zero.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>You will not receive any contingent quarterly payment
for any quarterly period where the closing price of the underlier on the applicable determination date is less than the downside threshold
level.</B> The terms of the securities differ from those of ordinary debt securities in that they do not provide for regular interest
payments. Instead, a contingent quarterly payment will be made with respect to a quarterly period only if the closing price of the underlier
is greater than or equal to the downside threshold level on the related determination date. If the closing price of the underlier is below
the downside threshold level on any determination date, you will not receive a contingent quarterly payment for the related quarterly
period. The closing price of the underlier could be below the downside threshold level on most or all of the determination dates so that
you receive few or no contingent quarterly payments over the term of the securities. If you do not receive sufficient contingent quarterly
payments over the term of the securities, the overall return on the securities may be less than the amount that would be paid on a conventional
debt security of the issuer of comparable maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>You will not participate in any appreciation in the value
of the underlier.</B> You will not participate in any appreciation in the value of the underlier from the initial underlier value even
though you will be exposed to the depreciation in the value of the underlier if the securities have not been redeemed prior to maturity
and the final underlier value is less than the downside threshold level. The return on the securities will be limited to the contingent
quarterly payment that is paid with respect to each determination date on which the closing price of the underlier is greater than or
equal to the downside threshold level. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Automatic early redemption risk.</B> The term of your
investment in the securities may be limited to as short as approximately three months by the automatic early redemption feature of the
securities. If the securities are redeemed prior to maturity, no further contingent quarterly payments will be made on the securities
and you may be forced to reinvest in a lower interest rate environment. There is no guarantee that you would be able to reinvest the proceeds
from an investment in the securities in a comparable investment with a similar level of risk in the event the securities are redeemed
prior to the maturity date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Any payment on the securities will be determined based
on the closing prices of the underlier on the dates specified.</B> Any payment on the securities will be determined based on the closing
prices of the underlier on the dates specified. You will not benefit from any more favorable value of the underlier determined at any
other time.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Contingent repayment of principal applies only at maturity
or upon any automatic early redemption.</B> You should be willing and able to hold the securities to maturity or any automatic early redemption.
If you sell the securities prior to maturity in the secondary market, if any, you may have to sell the securities at a loss relative to
your initial investment even if the price of the underlier is above the downside threshold level.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The securities are subject to volatility risk.</B> Volatility
is a measure of the degree of variation in the price of the underlier over a period of time. The contingent quarterly payment is determined
based on a number of factors, including the expected volatility of the underlier. The contingent quarterly payment is higher than the
fixed rate that we would pay on a conventional debt security of the same tenor and is higher than it otherwise would be if the level of
expected volatility of the underlier taken into account in determining the terms of the securities were lower. As volatility of the underlier
increases, there will typically be a greater likelihood that (a) the closing price of the underlier will be less than the downside threshold
level on one or more determination dates and (b) the final underlier value will be less than the downside threshold level.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Accordingly, you should understand that a higher contingent
quarterly payment reflects, among other things, an indication of a greater likelihood that you will (a) not receive contingent quarterly
payments with respect to one or more determination dates and/or (b) incur a loss of principal at maturity than would have been the case
had the contingent quarterly payment been lower. In addition, actual volatility over the term of the securities may be significantly higher
than the expected volatility at the time the terms of the securities were determined. If actual volatility is higher than expected, you
will face an even greater risk that you will not receive contingent quarterly payments and/or that you will lose a significant portion
or all of your principal at maturity for the reasons described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Investing in the securities is not equivalent to investing
in the underlier.</B> Investors in the securities will not own the underlier or have voting rights or rights to receive dividends or other
distributions or any other rights with respect to the underlier.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Tax treatment.</B> <FONT STYLE="background-color: white">Significant
aspects of the tax treatment of the securities are uncertain. You should consult your tax advisor about your tax situation. See &ldquo;Additional
provisions&mdash;Tax considerations&rdquo; below.</FONT></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Credit of issuer. </B>The securities are unsecured and
unsubordinated debt obligations of the issuer, Barclays Bank PLC, and are not, either directly or indirectly, an obligation of any third
party. Any payment to be made on the securities, including any repayment of principal, is subject to the ability of Barclays Bank PLC
to satisfy its obligations as they come due and is not guaranteed by any third party. As a result, the actual and perceived creditworthiness
of Barclays Bank PLC may affect the market value of the securities and, in the event Barclays Bank PLC were to default on its obligations,
you might not receive any amount owed to you under the terms of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; background-color: white"><B>You may lose some or all of your
investment if any U.K. Bail-in Power is exercised by the relevant U.K. resolution authority. </B>Notwithstanding and to the exclusion
of any other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or
beneficial owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder
or beneficial owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in
Power by the relevant U.K. resolution authority as set forth under &ldquo;Consent to U.K. Bail-in Power&rdquo; in this document. Accordingly,
any U.K. Bail-in Power may be exercised in such a manner as to result in you and other holders and beneficial owners of the securities
losing all or a part of the value of your investment in the securities or receiving a different security from the securities, which may
be worth significantly less than the securities and which may have significantly fewer protections than those typically afforded to debt
securities. Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power without providing any advance notice
to, or requiring the consent of, the holders and beneficial owners of the securities. The exercise of any U.K. Bail-in Power by the relevant
U.K. resolution authority with respect to the securities will not be a default or an Event of Default (as each term is defined in the
senior debt securities indenture) and the trustee will not be liable for any action that the trustee takes, or abstains from taking, in
either case, in accordance with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities.
See &ldquo;Consent to U.K. Bail-in Power&rdquo; in this document as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks
Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is failing or likely
to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially
adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>Risks Relating to the Underlier</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>No affiliation with the issuer of the underlier.</B> The
issuer of the underlier is not an affiliate of ours, is not involved with this offering in any way, and has no obligation to consider
your interests in taking any corporate actions that might affect the value of the securities. We have not made any due diligence inquiry
with respect to the issuer of the underlier in connection with this offering.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Single equity risk.</B> The price of the underlier can
rise or fall sharply due to factors specific to the underlier and its issuer, such as stock price volatility, earnings, financial conditions,
corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors,
such as general stock market volatility and levels, interest rates and economic and political conditions. We urge you to review financial
and other information filed periodically with the SEC by the issuer of the underlier.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Anti-dilution protection is limited, and the calculation
agent has discretion to make anti-dilution adjustments. </B>The calculation agent may in its sole discretion make adjustments affecting
the amounts payable on the securities upon the occurrence of certain corporate events (such as stock splits or extraordinary or special
dividends) that the calculation agent determines have a diluting or concentrative effect on the theoretical value of the underlier. However,
the calculation agent might not make such adjustments in response to all events that could affect the underlier. The occurrence of any
such event and any adjustment made by the calculation agent (or a determination by the calculation agent not to make any adjustment) may
adversely affect the market price of, and any amounts payable on, the securities. See &ldquo;Reference Assets&mdash;Equity Securities&mdash;Share
Adjustments Relating to Securities with an Equity Security as a Reference Asset&rdquo; in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Reorganization or other events could adversely affect
the value of the securities or result in the securities being accelerated.</B> Upon the occurrence of certain reorganization events or
a nationalization, expropriation, liquidation, bankruptcy, insolvency or de-listing of the underlier, the calculation agent may replace
the underlier with shares of another company identified as described in the prospectus supplement or, in some cases, with shares, cash
or other assets distributed to holders of the underlier upon the occurrence of that event. In the alternative, the calculation agent may
accelerate the maturity date for a payment determined by the calculation agent or may make other changes to the terms of the securities
to account for the occurrence of that event. Any decision by the calculation agent to replace the underlier, to accelerate the securities
or </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">to otherwise adjust the terms of the securities could adversely
affect the value of, and any amount payable on, the securities, perhaps significantly, and could result in a significantly lower return
on the securities than if the calculation agent had made a different decision. See &ldquo;Reference Assets&mdash;Equity Securities&mdash;Share
Adjustments Relating to Securities with an Equity Security as a Reference Asset&rdquo; in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Governmental legislative or regulatory actions, such as
sanctions, could adversely affect your investment in the securities.</B> Governmental legislative or regulatory actions, including, without
limitation, sanctions-related actions by the U.S. or a foreign government, could prohibit or otherwise restrict persons from holding the
securities or the underlier, or engaging in transactions in them, and any such action could adversely affect the value of the underlier.
These legislative or regulatory actions could result in restrictions on the securities or the de-listing of the underlier. You may lose
a significant portion or all of your initial investment in the securities if the underlier is de-listed or if you are forced to divest
the securities due to government mandates, especially if such de-listing occurs or such divestment must be made at a time when the value
of the securities has declined. See &ldquo;&mdash;Reorganization or other events could adversely affect the value of the securities or
result in the securities being accelerated&rdquo; above.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>We may accelerate the securities if a change-in-law event
occurs.</B> Upon the occurrence of legal or regulatory changes that may, among other things, prohibit or otherwise materially restrict
persons from holding the securities or the underlier, or engaging in transactions in them, the calculation agent may determine that a
change-in-law event has occurred and accelerate the maturity date for a payment determined by the calculation agent in its sole discretion.
Any amount payable upon acceleration could be significantly less than any amount that would be due on the securities if they were not
accelerated. However, if the calculation agent elects not to accelerate the securities, the value of, and any amount payable on, the securities
could be adversely affected, perhaps significantly, by the occurrence of those legal or regulatory changes. See &ldquo;Terms of the Notes&mdash;Change-in-Law
Events&rdquo; in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>Risks Relating to Conflicts of Interest</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>We may engage in business with or involving the issuer
of the underlier without regard to your interests.</B> We or our affiliates may presently or from time to time engage in business with
the issuer of the underlier without regard to your interests and thus may acquire non-public information about the issuer of the underlier.
Neither we nor any of our affiliates undertakes to disclose any such information to you. In addition, we or our affiliates from time to
time have published and in the future may publish research reports with respect to the issuer of the underlier, which may or may not recommend
that investors buy or hold the underlier.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Hedging and trading activity by the issuer and its affiliates
could potentially adversely affect the value of the securities.</B> Hedging or trading activities of the issuer&rsquo;s affiliates and
of any other hedging counterparty with respect to the securities could adversely affect the value of the underlier and, as a result, could
decrease the amount an investor may receive on the securities at maturity, if any. Any of these hedging or trading activities on or prior
to the pricing date could potentially increase the initial underlier value and, as a result, the downside threshold level, which is the
price at or above which the underlier must close on each determination date in order for you to receive a contingent quarterly payment
or, if the securities are not redeemed prior to maturity, in order for you to avoid being exposed to the negative performance of the underlier
at maturity. Additionally, such hedging or trading activities during the term of the securities could potentially affect the price of
the underlier on the determination dates and, accordingly, whether investors will receive one or more contingent quarterly payments, whether
the securities are automatically redeemed prior to maturity and, if the securities are not redeemed prior to maturity, the payment at
maturity, if any. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 12pt; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>We and our affiliates, and any dealer participating in
the distribution of the securities, may engage in various activities or make determinations that could materially affect your securities
in various ways and create conflicts of interest. </B>We and our affiliates play a variety of roles in connection with the issuance of
the securities, as described below. In performing these roles, our and our affiliates&rsquo; economic interests are potentially adverse
to your interests as an investor in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">In connection with our normal business activities and in connection
with hedging our obligations under the securities, we and our affiliates make markets in and trade various financial instruments or products
for our accounts and for the account of our clients and otherwise provide investment banking and other financial services with respect
to these financial instruments and products. These financial instruments and products may include securities, derivative instruments or
assets that may relate to the underlier. In any such market making, trading and hedging activity, investment banking and other financial
services, we or our affiliates may take positions or take actions that are inconsistent with, or adverse to, the investment objectives
of the holders of the securities. We and our affiliates have no obligation to take the needs of any buyer, seller or holder of the securities
into account in conducting these activities. Such market making, trading and hedging activity, investment banking and other financial
services may negatively impact the value of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">In addition, the role played by Barclays Capital Inc., as
the agent for the securities, could present significant conflicts of interest with the role of Barclays Bank PLC, as issuer of the securities.
For example, Barclays Capital Inc. or its representatives may derive compensation or financial benefit from the distribution of the securities
and such compensation or financial benefit may serve as an incentive to sell the securities instead of other investments. Furthermore,
we and our affiliates establish the offering price of the securities for initial sale to the public, and the offering price is not based
upon any independent verification or valuation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Furthermore, the selected dealer or its affiliates will have
the option to conduct a material portion of the hedging activities for us in connection with the securities. The selected dealer or its
affiliates would expect to realize a projected profit from such hedging activities, and this projected profit would be in addition to
any selling concession that the selected dealer realizes for the sale of the securities to you.&nbsp;This additional projected profit
may create a further incentive for the selected dealer to sell the securities to you.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">In addition to the activities described above, we will also
act as the calculation agent for the securities. As calculation agent, we will determine any values of the underlier and make any other
determinations necessary to calculate any payments on the securities. In making these determinations, we may be required to make discretionary
judgments, including those described in the accompanying prospectus supplement and under &ldquo;&mdash;Risks Relating to the Underlier&rdquo;
above. In making these discretionary judgments, our economic interests are potentially adverse to your interests as an investor in the
securities, and any of these determinations may adversely affect any payments on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"><B>Risks Relating to the Estimated Value of the Securities
and the Secondary Market</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The securities will not be listed on any securities exchange,
and secondary trading may be limited.</B> Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to offer to purchase
the securities in the secondary market but are not required to do so and may cease any such market making activities at any time, without
notice. Even if a secondary market develops, it may not provide enough liquidity to allow you to trade or sell the securities easily.
Because other dealers are not likely to make a secondary market for the securities, the price, if any, at which you may be able to trade
your securities is likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are
willing to buy the securities. In addition, Barclays Capital Inc. or one or more of our other affiliates may at any time hold an unsold
portion of the securities (as described on the cover page of this document), which may inhibit the development of a secondary market for
the securities. The securities are not designed to be short-term trading instruments. Accordingly, you should be willing and able to hold
your securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The market price of the securities will be influenced
by many unpredictable factors.</B> Several factors will influence the value of the securities in the secondary market and the price at
which Barclays Capital Inc. and other affiliates of Barclays Bank PLC may be willing to purchase or sell the securities in the secondary
market. Although we expect that generally the value of the underlier on any day will affect the value of the securities more than any
other single factor, other factors that may influence the value of the securities include: </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD>the volatility (frequency and magnitude of changes in value) of the underlier;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD>whether the closing price has been, or is expected to be, below the downside threshold level on any determination date;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD>dividend rates on the underlier;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD>interest and yield rates in the market;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD>time remaining until the securities mature;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD>supply and demand for the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD>geopolitical conditions and economic, financial, political, regulatory and judicial events that affect the underlier and that may
affect the final underlier value; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD>any actual or anticipated changes in our credit ratings or credit spreads.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">The value of the underlier may be, and has recently been,
volatile, and we can give you no assurance that the volatility will lessen. See &ldquo;Pfizer Inc. Overview&rdquo; below. You may receive
less, and possibly significantly less, than the stated principal amount if you try to sell your securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 12pt; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The estimated value of your securities is expected to
be lower than the initial issue price of your securities. </B>The estimated value of your securities on the pricing date is expected to
be lower, and may be significantly lower, than the initial issue price of your securities. The difference between the initial issue price
of your securities and the estimated value of the securities is expected as a result of certain factors, such as any sales commissions
expected to be paid to Barclays Capital Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees expected
to be allowed or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection
with structuring the securities, the estimated cost that we may incur in hedging our obligations under the securities, and estimated development
and other costs that we may incur in connection with the securities. These other costs will include a fee paid to LFT Securities, LLC,
an entity in which an affiliate of Morgan Stanley Wealth Management has an ownership interest, for providing certain electronic platform
services with respect to this offering.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 12pt; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The estimated value of your securities might be lower
if such estimated value were based on the levels at which our debt securities trade in the secondary market. </B>The estimated value of
your securities on the pricing date is based on a number of variables, including our internal funding rates. Our internal funding rates
may vary from the levels at which our benchmark debt securities trade in the secondary market. As a result of this difference, the estimated
values referenced above might be lower if such estimated values were based on the levels at which our benchmark debt securities trade
in the secondary market.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 12pt; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The estimated value of the securities is based on our
internal pricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions.
</B>The estimated value of your securities on the pricing date is based on our internal pricing models, which take into account a number
of variables and are based on a number of subjective assumptions, which may or may not materialize. These variables and assumptions are
not evaluated or verified on an independent basis. Further, our pricing models may be different from other financial institutions&rsquo;
pricing models and the methodologies used by us to estimate the value of the securities may not be consistent with those of other financial
institutions that may be purchasers or sellers of securities in the secondary market. As a result, the secondary market price of your
securities may be materially different from the estimated value of the securities determined by reference to our internal pricing models.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 12pt; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The estimated value of your securities is not a prediction
of the prices at which you may sell your securities in the secondary market, if any, and such secondary market prices, if any, will likely
be lower than the initial issue price of your securities and may be lower than the estimated value of your securities.</B> The estimated
value of the securities will not be a prediction of the prices at which Barclays Capital Inc., other affiliates of ours or third parties
may be willing to purchase the securities from you in secondary market transactions (if they are willing to purchase, which they are not
obligated to do). The price at which you may be able to sell your securities in the secondary market at any time will be influenced by
many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially
less than our estimated value of the securities. Further, as secondary market prices of your securities take into account the levels at
which our debt securities trade in the secondary market, and do not take into account our various costs related to the securities such
as fees, commissions, discounts, and the costs of hedging our obligations under the securities, secondary market prices of your securities
will likely be lower than the initial issue price of your securities. As a result, the price at which Barclays Capital Inc., other affiliates
of ours or third parties may be willing to purchase the securities from you in secondary market transactions, if any, will likely be lower
than the price you paid for your securities, and any sale prior to the maturity date could result in a substantial loss to you.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 12pt; color: #A9C4EB">&sect;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The temporary price at which we may initially buy the
securities in the secondary market and the value we may initially use for customer account statements, if we provide any customer account
statements at all, may not be indicative of future prices of your securities.</B> Assuming that all relevant factors remain constant after
the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market (if Barclays
Capital Inc. makes a market in the securities, which it is not obligated to do) and the value that we may initially use for customer account
statements, if we provide any customer account statements at all, may exceed our estimated value of the securities on the pricing date,
as well as the secondary market value of the securities, for a temporary period after the initial issue date of the securities. The price
at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market and the value that we may initially use
for customer account statements may not be indicative of future prices of your securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Pfizer Inc. Overview</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">According to publicly available information, Pfizer Inc. (the &ldquo;Company&rdquo;)
is a biopharmaceutical company that discovers, develops, manufactures, markets, sells and distributes biopharmaceutical products.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information filed by the Company with the SEC under the Securities Exchange
Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), can be located by reference to its SEC file number: 001-03619. The Company&rsquo;s
common stock is listed on the New York Stock Exchange under the ticker symbol &ldquo;PFE.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We urge you to read the following section in the accompanying prospectus
supplement: &ldquo;Reference Assets&mdash;Equity Securities&mdash;Reference Asset Issuer and Reference Asset Information.&rdquo; Companies
with securities registered under the Exchange Act are required to file financial and other information specified by the SEC periodically.
Information provided to or filed with the SEC by the Company can be located on a website maintained by the SEC at http://www.sec.gov by
reference to the Company&rsquo;s SEC file number provided above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The summary information above regarding the Company comes from the Company&rsquo;s
SEC filings. You are urged to refer to the SEC filings made by the Company and to other publicly available information (such as the Company&rsquo;s
annual report) to obtain an understanding of the Company&rsquo;s business and financial prospects. The summary information contained above
is not designed to be, and should not be interpreted as, an effort to present information regarding the financial prospects of any issuer
or any trends, events or other factors that may have a positive or negative influence on those prospects or as an endorsement of any particular
issuer.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Information from outside sources is not incorporated by reference
in, and should not be considered part of, this document or the accompanying prospectus or prospectus supplement. We have not independently
verified the accuracy or completeness of the information contained in outside sources.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information about the underlier as of market close on October 8, 2025:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 75%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 4pt; width: 41%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Bloomberg Ticker Symbol:</B></FONT></TD>
    <TD STYLE="padding: 4pt; width: 26%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">PFE UN&lt;Equity&gt;</FONT></TD>
    <TD STYLE="padding: 4pt; width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>52 Week High:</B></FONT></TD>
    <TD STYLE="padding: 4pt; width: 13%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$30.19</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Current Closing Price:</B></FONT></TD>
    <TD STYLE="padding: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.68</FONT></TD>
    <TD STYLE="padding: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>52 Week Low:</B></FONT></TD>
    <TD STYLE="padding: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$21.59</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>52 Weeks Ago (10/9/2024):</B></FONT></TD>
    <TD STYLE="padding: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$30.19</FONT></TD>
    <TD STYLE="padding: 4pt">&nbsp;</TD>
    <TD STYLE="padding: 4pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following table sets forth the published high, low and period-end
closing prices of the underlier for each quarter for the period of January 2, 2020 through October 8, 2025. The associated graph shows
the closing prices of the underlier for each day in the same period. The closing price of the underlier on October 8, 2025 was $25.68.
We obtained the closing prices of the underlier from Bloomberg Professional<SUP>&reg;</SUP> service, without independent verification.
Historical performance of the underlier should not be taken as an indication of future performance. Future performance of the underlier
may differ significantly from historical performance, and no assurance can be given as to the closing price of the underlier during the
term of the securities, including on any of the determination dates. We cannot give you assurance that the performance of the underlier
will not result in a loss on your initial investment. <I>The closing prices below may reflect adjustments in response to certain corporate
actions, such as stock splits, public offerings, mergers and acquisitions, spin-offs, extraordinary dividends, delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #296DC1">
    <TD STYLE="width: 49%; border-top: white 1.5pt solid; border-left: white 1.5pt solid; font-size: 12pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Common Stock of Pfizer Inc.</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 17%; border-top: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>High</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 17%; border-top: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Low</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 17%; border-top: white 1.5pt solid; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Period End</B></FONT></TD></TR>
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>2020</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: white 1.5pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">First Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$38.59</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$27.01</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$30.94</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Second Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$36.51</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$30.10</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$31.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Third Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$37.22</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$31.72</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$34.79</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Fourth Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$42.56</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$33.44</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$36.81</FONT></TD></TR>
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>2021</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: white 1.5pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">First Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$37.77</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$33.49</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$36.23</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Second Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$40.68</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$35.91</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$39.16</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Third Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$50.42</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$39.25</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$43.01</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Fourth Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$61.25</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$41.32</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$59.05</FONT></TD></TR>
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>2022</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: white 1.5pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">First Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$56.69</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$45.75</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$51.77</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Second Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$55.17</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$46.53</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$52.43</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Third Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$53.42</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$43.76</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$43.76</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Fourth Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$54.48</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$41.75</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$51.24</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #296DC1">
    <TD STYLE="border-top: white 1.5pt solid; border-left: white 1.5pt solid; font-size: 12pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Common Stock of Pfizer Inc.</B></FONT></TD>
    <TD STYLE="border-top: white 1.5pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>High</B></FONT></TD>
    <TD STYLE="border-top: white 1.5pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Low</B></FONT></TD>
    <TD STYLE="border-top: white 1.5pt solid; vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Period End</B></FONT></TD></TR>
<TR STYLE="background-color: #DCEBF4">
    <TD STYLE="border-left: white 1.5pt solid; width: 49%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>2023</B></FONT></TD>
    <TD STYLE="text-align: center; width: 17%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 17%">&nbsp;</TD>
    <TD STYLE="border-right: white 1.5pt solid; text-align: center; width: 17%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">First Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$51.26</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$39.39</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$40.80</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Second Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$41.79</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$36.12</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$36.68</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Third Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$37.51</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$32.09</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$33.17</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Fourth Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$33.94</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$26.13</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$28.79</FONT></TD></TR>
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>2024</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: white 1.5pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">First Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$29.73</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.89</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$27.75</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Second Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$29.60</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.26</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$27.98</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Third Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$31.39</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$27.70</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$28.94</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Fourth Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$30.19</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$24.80</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$26.53</FONT></TD></TR>
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>2025</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: white 1.5pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">First Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$27.13</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.01</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.34</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Second Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$24.84</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$21.59</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$24.24</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Third Quarter</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.88</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$23.29</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.48</FONT></TD></TR>
  <TR>
    <TD STYLE="border-left: white 1.5pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Fourth Quarter (through October 8, 2025)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$27.37</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.68</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1.5pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.68</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 90%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="padding-top: 4pt; width: 100%; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Pfizer Inc. common stock &mdash; daily closing prices*<BR>
January 2, 2020 to October 8, 2025</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><IMG SRC="image_002.gif" ALT="" STYLE="height: 321px; width: 613px"></B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">* The dotted line indicates a hypothetical downside threshold level of 75% of the closing price of the underlier on October 8, 2025. The actual downside threshold level will be equal to 75% of the initial underlier value.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Additional Information about the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please read this information in conjunction with the terms on the cover
page of this document.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #296DC1">
    <TD STYLE="width: 23%; border-top: #4F81BD 1pt solid; border-left: #4F81BD 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Additional provisions:</B></FONT></TD>
    <TD STYLE="width: 77%; border-top: #4F81BD 1pt solid; border-right: #4F81BD 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Minimum ticketing size:</B></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000 / 1 security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Tax considerations:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should review carefully the sections in the accompanying prospectus
    supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as
    Prepaid Forward or Derivative Contracts with Associated Coupons&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax Consequences
    to Non-U.S. Holders.&rdquo;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In determining our reporting responsibilities, if any, we intend to
    treat (i) the securities for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons and (ii)
    any contingent quarterly payments as ordinary income, as described in the section entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax
    Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward or Derivative Contracts with Associated Coupons&rdquo; in the accompanying
    prospectus supplement. Our special tax counsel, Davis Polk &amp; Wardwell LLP, has advised that it believes this treatment to be reasonable,
    but that there are other reasonable treatments that the Internal Revenue Service (the &ldquo;IRS&rdquo;) or a court may adopt.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Sale, exchange or redemption of a security.</I> Assuming the treatment
    described above is respected, upon a sale or exchange of the securities (including redemption upon an automatic call or at maturity),
    you should recognize capital gain or loss equal to the difference between the amount realized on the sale or exchange and your tax basis
    in the securities, which should equal the amount you paid to acquire the securities (assuming contingent quarterly payments are properly
    treated as ordinary income, consistent with the position referred to above). This gain or loss should be short-term capital gain or loss
    unless you hold the securities for more than one year, in which case the gain or loss should be long-term capital gain or loss, whether
    or not you are an initial purchaser of the securities at the issue price. The deductibility of capital losses is subject to limitations.
    If you sell your securities between the time your right to a contingent quarterly payment is fixed and the time it is paid, it is likely
    that you will be treated as receiving ordinary income equal to the contingent quarterly payment. Although uncertain, it is possible that
    proceeds received from the sale or exchange of your securities prior to a determination date but that can be attributed to an expected
    contingent quarterly payment could be treated as ordinary income. You should consult your tax advisor regarding this issue.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As noted above, there are other reasonable treatments that the IRS or
    a court may adopt, in which case the timing and character of any income or loss on the securities could be materially affected. In addition,
    in 2007 the U.S. Treasury Department and the IRS released a notice requesting comments on the U.S. federal income tax treatment of &ldquo;prepaid
    forward contracts&rdquo; and similar instruments. The notice focuses in particular on whether to require investors in these instruments
    to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of
    income or loss with respect to these instruments, the relevance of factors such as the nature of the underlying property to which the
    instruments are linked, and whether investors in short-term instruments should be required to accrue income. While the notice requests
    comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration
    of these issues could materially affect the tax consequences of an investment in the securities, possibly with retroactive effect. You
    should consult your tax advisor regarding the U.S. federal income tax consequences of an investment in the securities, including possible
    alternative treatments and the issues presented by this notice.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Non-U.S. holders.</I> Insofar as we have responsibility as a withholding
    agent, we do not currently intend to treat contingent quarterly payments to non-U.S. holders (as defined in the accompanying prospectus
    supplement) as subject to U.S. withholding tax. However, non-U.S. holders should in any event expect to be required to provide appropriate
    Forms W-8 or other documentation in order to establish an exemption from backup withholding, as described under the heading &ldquo;&mdash;Information
    Reporting and Backup Withholding&rdquo; in the accompanying prospectus supplement. If any withholding is required, we will not be required
    to pay any additional amounts with respect to amounts withheld.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Treasury regulations under Section 871(m) generally impose a withholding
    tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent IRS notice excludes
    from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo; with respect
    to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying Security&rdquo;).
    Based on our determination that the securities do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations, we expect
    that these regulations will not apply to the securities with regard to non-U.S. holders. Our determination is not binding on the IRS,
    and the IRS may disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances,
    including whether you enter into other transactions with respect to an Underlying Security. If necessary, further information regarding
    the potential</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5pt 0pt 0; text-align: right; color: Red"><B><IMG SRC="image_010.jpg" ALT=""></B></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Contingent Income Auto-Callable Securities due October 22, 2026</P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Based on the Performance of the Common Stock of Pfizer Inc.</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"><B>Principal at Risk Securities</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: gray"></P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: #296DC1 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0">application of Section 871(m) will be provided in the pricing supplement for the securities. You should consult your tax advisor regarding the potential application of Section 871(m) to the securities.</P>
        <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="width: 23%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Trustee:</B></FONT></TD>
    <TD STYLE="width: 77%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The Bank of New York Mellon </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>Use of proceeds and hedging:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The net proceeds we receive from the sale of the securities will be
    used for various corporate purposes as set forth in the prospectus and prospectus supplement and, in part, in connection with hedging
    our obligations under the securities through one or more of our subsidiaries.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We, through our subsidiaries or others, hedge our anticipated exposure
    in connection with the securities by taking positions in futures and options contracts on the underlier and any other securities or instruments&nbsp;we
    may wish to use in connection with such hedging. Trading and other transactions by us or our affiliates could affect the value of the
    underlier, the market value of the securities or any amounts payable on the securities. For further information on our use of proceeds
    and hedging, see &ldquo;Use of Proceeds and Hedging&rdquo; in the prospectus supplement.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #296DC1"><B>ERISA:</B></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">See &ldquo;Benefit Plan Investor Considerations&rdquo; in the accompanying prospectus supplement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>This document represents a summary of the terms and conditions of
the securities. We encourage you to read the accompanying prospectus and prospectus supplement for this offering, which can be accessed
via the hyperlinks on the cover page of this document.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Supplemental Plan of Distribution</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Morgan Stanley Smith Barney LLC (&ldquo;Morgan Stanley Wealth Management&rdquo;)
and its financial advisors will collectively receive from the agent, Barclays Capital Inc., a fixed sales commission for each security
they sell, and Morgan Stanley Wealth Management will receive a structuring fee for each security, in each case as specified on the cover
page of this document.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="color: rgb(41,109,193)">October 2025</FONT></TD><TD STYLE="text-align: right; font-size: 10pt; color: #59AE43; width: 50%"><FONT STYLE="font-size: 10pt; color: rgb(41,109,193)">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
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MMIN;FV%A8>+BXM#0T"TM+=34U.;FY@  GP  "%-3JRPLTS@XQT='MP  EP
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M$#@X.,_/SW!P<%A86
M
M
M
M
M
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MD"0M2:*CP8 ')F*]*Q[D8 BD7N@\4,8)[E0%\=.(3FLW2L2=5"?GC(1+T68
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M;2UEF 271QI"%2M855Q8EL*KLW9/9<0D3U+Y-%6M]"YI,4P*79TI&/J5A8*
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JPS$DPS(TPS-$PS14PS5DPS9TPS>$PSB4PSFDPSJTPSO$PSS40R\)"  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  N +0# 2(  A$! Q$!_\0
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M#4%MX8S<F5!"@! *C _+73?^",>N:79SZ3;_ +7GQ,T[PWJ5P[W^@>&K'5]
MT;4+B>.*"9KK1=/\80:/>&:*UABN6GL'9TB17W#(?]]Q!&'=O+C&X+T0!O3D
M@9(&.!V!(Z<4HCC"#Y%('12%QR<'M@Y)+'CJ3VXJ.'_$'BOAG+9Y1DN8QPF
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,BDK**LDDMEZ*W__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %H T0# 2(  A$! Q$!_\0
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MRUSXFLZ-)S2O8Z,-25:JH-VN;_\ :FG_ //];?\ ?Y?\:/[4T_\ Y_K;_O\
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M5?B']DP_F?X'I7]J:?\ \_UM_P!_E_QH_M33_P#G^MO^_P O^->:T4?VM/\
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MG_\ /];?]_E_QH_M33_^?ZV_[_+_ (UYK11_:T_Y5^(?V3#^9_@>E?VII_\
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M(V-V3\IYKR/J6'O;D7;Y_>>BL=7M?G?<['_A$-/_ .>US_WTO_Q-'_"(:?\
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M2P>':?N+^OF#QV(3MSL]#_X1#3_^>US_ -]+_P#$T?\ "(:?_P ]KG_OI?\
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M;B<*A)QN'EH>,DE2.P SD<GH_BC6M<T^R276#I[+9W=R]R(H2TYBE* -D,F
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MU'3Y(WO8H8Y@7+[@1$  /E& 0&_#!I+!X=VM!?U;_,4L?7BK\[_J_EY':_\
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M'+#! P.AI+!X=_87]?/N5+&UU]M_TK_D=9_PB&G_ //:Y_[Z7_XFC_A$-/\
M^>US_P!]+_\ $UY^_CSQ$+_[(+H%A%_9.1 N[^TBQ ?&.FT;L=/:MV'5]?2[
MENWUDO!'KATX6SP1A#$<#+,%W;@><@@>H-+ZIAK7Y%_7S\U]Y+QU=:<[_KY>
MIT?_  B&G_\ /:Y_[Z7_ .)H_P"$0T__ )[7/_?2_P#Q-<4/$.L?V-J$&K7;
M3W,MF+F$/#;3VL@$B@O"Z=4^8#;(I;ODT:CJVH7ESI.JSWY8QZY<0QZ9Y:!4
M\I)E4@@;RQ !.21\PP!0\)AUO!?U?S\A_7<1>W.SM?\ A$-/_P">US_WTO\
M\31_PB&G_P#/:Y_[Z7_XFN?\%:_K^HW]B=1\^2VO[%KDFX:T4*X*_P"I6)RY
MC^8@[P2#C)YQ6?K-K=OXHU01:I.COJVGK'N2-A#E<Y4;<Y'.,DCU!IRP5"+2
M<%K_ )V$\?7Y7+G?]?([#_A$-/\ ^>US_P!]+_\ $T?\(AI__/:Y_P"^E_\
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M!VHI_4L/_(OZ^97US$?SO^OD<_\ \(AI_P#SVN?^^E_^)H_X1#3_ /GM<_\
M?2__ !-=!12^IX?^1?U\P^N8C^=_U\CG_P#A$-/_ .>US_WTO_Q-'_"(:?\
M\]KG_OI?_B:Z"BCZGA_Y%_7S#ZYB/YW_ %\CG_\ A$-/_P">US_WTO\ \370
M445M3HTZ5^16N95*U2K;G=[!1116ID%<A\4?^2<ZK_VQ_P#1R5U]<A\4?^2<
MZK_VQ_\ 1R5I2_B1]2*GP,^<:***]T\D**** "BBB@ HHHH **** "OKVOD*
MOJ;Q1J4^D>&-0U"VV":"$LC.,JI_O$>@Z_A7G8YV4?Z[';A>I8LM"TC3;F:Y
ML=*L;6>?_6RP6Z(TG?YB!D_C38/#^BVL<T=OI%A"D[B258[9%$C@Y#, .2"
M<GO7FE_J6JZ'XHU..UU.YU*ZN5T^V-VD=N)45C.W .R+=Z%L#YAG)ZW(+_6I
M];TJXO[F[6:Q>^58F-LSS!8U8"41;E5^<$*1T!P,UYKDHJ_]=?\ +^K'5>[_
M *\O\ST<Z=8EG8V=ON>43LWE+EI   YX^\  ,]>!6=HWA/1=#M6BM;&!GD0I
M+/)$AEF4DG#L -PYZ&O/X/%OBDZ(UV\TZF[TXW4<MQ]CQ')N0 PI&[,T>&(.
M\$@XR><5I:O?^(],N=2$'B&:5=/>R1%GMH")3,^U]^U%XP>-NWIU-5:TK==A
M<R_7^ON.TM_#>A6<7E6VBZ=!'@#9%:HHP&W#@#LPS]>:GGT?2[J_AO[C3;.:
M]@_U5Q) K21_[K$9'X5YSJ>N:M:7+V\MZMU-I^JW,,-S/;1&3:+!I5/"@ AF
MQE0,@8.<G-I=>UC3K:+^T-?D<WNF07*R_8HW:.9Y$3;&BA<[MP W$X//3BB^
MS&VD['H-W86=^(A>6D%R(G$D8FC#[''1AD<$>M,72].18E6PM56*$V\8$*@)
M$<90<<+P..G ]*\RCU/5-8N8[2YU2_46'B&"&.26.W69E,6[$@12F02<8 //
M(STELM?U673[M(M5BTE--L'O4V6T06X8RS A@5P$&P [=IRV<^L\RUOZ_*R_
MS]1W][E_K<](T_2].TBW-OIMA:V4).XQVT*QKGUPH J)]!T>6YN;B32;%Y[I
M/+N)6MD+3+_=<XRP]C7 ?\)'XAF.I:H-3:&&SN["-;$01["LRQ;U9BN_K(<8
M((/J.*Z?Q%?WQ\0:?I-MJ)TV&:UN+E[E41F8Q[,)\X(QAB3QG"\$=:J3<5=_
MUI?\D"::TV_X;_-&VVC:6^I)J3Z;9M?HNQ+HP*957T#XR!^-1IX?T6*6YECT
MBP22Z_X^'6V0&;G/SG'S<^M>40^)=0TKP!93Z=JUT)+#3()3;P6D1BW,3S+)
M)R0P'"IM;ZD@5H7.J:MI>N:PMC=7TTFHZU#;D1+;[XE-JK_N_,"IN. HWDC
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MM+M%9;;3;.%65E81P*H*L<L#@=">3ZFF/H6D275M=/I5BUS:J%MYFMT+Q =
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M31K%*KP*PD1<[58$<@9. >!DU)::=96%L;:SL[>V@)R8H8E13QCH!CH*LT4
M9S>']%>2TD?2+!GLU"VS&V0F!1T"''RCZ5:6SM4NY;M;:%;F50DDPC =U&<
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M8XSP,8_&M6Z\ RV>EW1>^AEU.+4$LDMX@Y5V9<X!*]3D8Z# .3GBI^KT>_\
M7],OVM7M_6O^3/6_^%H^#?\ H,?^2TW_ ,11_P +1\&_]!C_ ,EIO_B*\=C^
M'^IW%W%;VU[I\Y>Y:UD>.1RL,H4MM?*YZ \C(]Z='\/=1FB@>#4=-E^T+*8%
M223,ACSO4908(QU.!Z&E["A_-_7W![6KV/8/^%H^#?\ H,?^2TW_ ,11_P +
M1\&_]!C_ ,EIO_B*\3L_!NH7VARZK!/:M%%$9I(P7+*@.#DA2N>^W=NQVK7U
M'P)#:+>BUN1>O;V,-R<2-&0S_P"R8SN!SP-P/J>U-X>BG:[!5JCUL>J_\+1\
M&_\ 08_\EIO_ (BC_A:/@W_H,?\ DM-_\17A>L^&I]$1_M%_I\D\<@CFMHIB
M98F(SR"!D>ZY -;R^$;5?#&D:G%I&MZI->H[2BSE 6+:V!_RR?K[GM0\/12O
M=B5:I>UCU;_A:/@W_H,?^2TW_P 11_PM'P;_ -!C_P EIO\ XBO%-+\'7^MV
M,UY8R6^$61Q;N[-)M3J"0NU3SP&*D]A6IIO@%1KUGI^JZA"3=6S7*Q6C-YBK
ML+*263;C(QC.?YTG0HJ]V_ZU&JU5]/ZO8]7_ .%H^#?^@Q_Y+3?_ !%'_"T?
M!O\ T&/_ "6F_P#B*\3D\&:A'#/.T]I]GBL$O_.WMM9&X51\N=V>,>W6KV@^
M%K74?"$^L&QU34+J.\^SBVL9 OR[0=Q_=N>]-X>BE>[$JU1NUCU[_A:/@W_H
M,?\ DM-_\11_PM'P;_T&/_):;_XBO(M2\#JFLW\-A?PI86@B\RXNV/R/)C$9
M**<MD]ACUQ2Z5\/[N34X8M7GALX#?"R*ESYDK=3Y>%(Z=S@4E0HM7NQNM570
M]<_X6CX-_P"@Q_Y+3?\ Q%'_  M'P;_T&/\ R6F_^(KQ^?P'>O=W"VDT*H;F
M>&SBG<^;<B(G=MPNWH.Y&31)\/K^*&6274],C$-O'<S O)F.-^C'"<_09/M0
MJ%!_:_K[@=6JG:Q[!_PM'P;_ -!C_P EIO\ XBC_ (6CX-_Z#'_DM-_\17CD
MG@#4;<Z@;N^TZVBL)(XY999'VG> 5(PA..1V!JS'X":WL;]M0O(X[RUO(;80
M*6"OOY!W!#]X$8..._I1["CW_K[@]K5['K7_  M'P;_T&/\ R6F_^(H_X6CX
M-_Z#'_DM-_\ $5X[<>![H:E>1"XM+.WANQ9QM<SLPDE(SL5E09^I51S3[;X=
M:O.EOON;&WFN)Y;>.&9WWM)'G<.%(['!SBCV%"U^;^ON#VM6]K'K_P#PM'P;
M_P!!C_R6F_\ B*/^%H^#?^@Q_P"2TW_Q%?.<L;0RO$XPZ,58>A%-K3ZG3[LA
MXF:T:/H[_A:/@W_H,?\ DM-_\11_PM'P;_T&/_):;_XBOG&BG]3I]V+ZS,^C
MO^%H^#?^@Q_Y+3?_ !%'_"T?!O\ T&/_ "6F_P#B*^<:*/J=/NP^LS/H[_A:
M/@W_ *#'_DM-_P#$4?\ "T?!O_08_P#):;_XBOG&BCZG3[L/K,SZ._X6CX-_
MZ#'_ )+3?_$4?\+1\&_]!C_R6F_^(KYQHH^IT^[#ZS,^CO\ A:/@W_H,?^2T
MW_Q%'_"T?!O_ $&/_):;_P"(KYQHH^IT^[#ZS,^CO^%H^#?^@Q_Y+3?_ !%'
M_"T?!O\ T&/_ "6F_P#B*^<:*/J=/NP^LS/H[_A:/@W_ *#'_DM-_P#$4?\
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M"G_0*_\ )B7_ .*H^LP#V$CP6BO>O^%=>%/^@5_Y,2__ !5'_"NO"G_0*_\
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MCK;XHM=:_L[/D60M/)\_[V$*[MVWCKG&/QKTK_A77A3_ *!7_DQ+_P#%4?\
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M_P F)?\ XJC_ (5UX4_Z!7_DQ+_\51]9@'L)'@M%>]?\*Z\*?] K_P F)?\
MXJC_ (5UX4_Z!7_DQ+_\51]9@'L)'@M%>]?\*Z\*?] K_P F)?\ XJC_ (5U
MX4_Z!7_DQ+_\51]9@'L)'@M%>]?\*Z\*?] K_P F)?\ XJC_ (5UX4_Z!7_D
MQ+_\51]9@'L)'@M%>]?\*Z\*?] K_P F)?\ XJC_ (5UX4_Z!7_DQ+_\51]9
M@'L)'@M>C_!7_D<;S_L'O_Z,CKL_^%=>%/\ H%?^3$O_ ,56SX9\*:)H6I27
M6FV7D3/"8V;S7;*D@XPQ(Z@5E5Q$90:1=.C)23.JHHHKS#O"N0^*/_).=5_[
M8_\ HY*Z^N0^*/\ R3G5?^V/_HY*TI?Q(^I%3X&?.-%%%>Z>2%%%% !1110
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M,I(H93WZ&I*+:M]R>QY7:0:AI.ELT%K);7%Y>S:;#$(# %CE(:-T1B<*GS'
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M0 5:L/\ 7M_N_P!156K5A_KV_P!W^HI2V&MS1HHHK U"N0^*/_).=5_[8_\
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M4;8V; QR3ZFO0Z*FVEBKZW/*K*VMH]#M9DO[J2+3M#>]E>WO)"9)ICGB0-N
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M>3MPTBJTA [D<@9YZGDQJEY;Z)*++5S=6YNX8;C47U)Q;%-A9W64J[0DG"D
MD*2,;3G'JE%#W!,\V@U"41V-OK6K-:Z//]H>&:"^F+2$%!'&)V5)'/+L,<L
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M5M=_\)'>Z<8K8)+IL%BCL\@'59&1@!]?TK/GK;KRZ>3Z>I?)2M;S?7T.#L?
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M]Y4W_+_@GSN.QWM/W=/;\_\ @!1117K'E!1110 55O\ _4+_ +W]#5JJM_\
MZA?][^AJH[B>QG4445L9!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5:L/\ 7M_N
M_P!156K5A_KV_P!W^HI2V&MS1HHHK U"N0^*/_).=5_[8_\ HY*Z^N0^*/\
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MD_\ ?_04?;)_[_Z"BT@O$G_L_P#Z:_\ CO\ ]>C^S_\ IK_X[_\ 7J#[9/\
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MG_\ 37_QW_Z]1?;IO]G\J/MTW^S^5'O![I+_ &?_ --?_'?_ *]']G_]-?\
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MDD.CRN\L08D7"W)Q"#ZA6) STQ7;R>*M)34;FP2YBDN;>W2Y9%FC&48X&"S
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M!RQ)X!P.O(H]E-6NMRO:PUL]C4HKG4UN\&I7EE%"MQ<FY*P122"-418HV;+
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M:/S+=@I9&QE3D'T'(P1V(K(TS7-0FM%:6!9;G[%;S$&=4CRY?YB=@(Z GKZ
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MG:2VL$@BD>&=&"N2!M)S@'GH:Y&;PSK-W86FE#3OL[VMK=V[:B94Q(TB$!E
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ML?\ T<E=?7(?%'_DG.J_]L?_ $<E:4OXD?4BI\#/G&BBBO=/)"BBB@ HHHH
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHZF@ ZFNQ\/\
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M_O?T-5'<3V,ZBBBMC(**** "BBB@ HHHH **** "BBB@"]I__+3\/ZU5N/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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%HI#/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $J T,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^HKJ;[-:
M33[=WE1L^W.,X&<5+535/^03>_\ 7!__ $$U$VU%M=F7!)R2?=&!_P )G_TX
M?^1O_L:/^$S_ .G#_P C?_8URE%?,?VAB/YOP1]-_9^'_E_%G5_\)G_TX?\
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M)_[0U"*U^Q^7OS\WFYQ@$],>U;-W<?9;5YMN[;CC.,\XKAO#?_(?M?\ @?\
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M_4N_^3O_ -KKR"BCZM2[![>IW/7_ /A>7_4N_P#D[_\ :Z/^%Y?]2[_Y._\
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MU./,@HHHJ"PHHHH U?#?_(?M?^!_^@&NSU?_ )!<W_ ?_0A7&>&_^0_:_P#
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M **** "BBB@ K;\/_P#+Q_P'^M8E;?A__EX_X#_6MJ'\1#6YE?%'_DG.J_\
M;'_T<E?.-?1WQ1_Y)SJO_;'_ -')7SC7U.#_ (;]3CQ/QA11178<P4444 %%
M%% %BPO)-/U"VO8@K26\JRH'&02IR,^W%6)]8NI]>?6?D2Z:X^T_(/E#[MW
M/;-9]%*RO<=W:QUESXVN-5\FWO(8+*V6]^W/+90LTGF\\@/)@Y/N/Z4_6?'5
MQ>^(=5O[2!%@O;4V2I.O*1''(P<!L@GN.>]<A14>RAV_K3_)%^TEW.EF\;ZG
M-!/$8;51-9163,JL"$C.5(^;[WOT]J)_&M[<7T%^]AIOVV.>.=[D0'S)F0 #
M<2W X&0NW-<U13]G&][$\\K6N=0GCS5HR62*T5CJ)U+.QO\ 6$8Q][[OMU]Z
MHV?B6YT_7Y]7M;:UC><.LEOAS$0XPPY;=@]>M8M%"IQ70;G)[LZE_'>H23(S
M6.G^2MB=/^SA'V&$G./O[LCU!JAHGB>^T"&ZBLHX,7$D4C%U)*F-MRXY]>N<
MUBT4*$5T%SR[G7R?$?6Y;N.Y,=H)([PW@(1OO%-A7EON[?Q]ZC'C[44FL6BL
M=/BBLHY8HX51]C))]X-ER?U!KE**7LH=A^TGW.LL_'^HV4,"16&G%K>"2WAD
M=)"R1.<E!\_0=B>>.IYJO_PFVI?VM_:7D6GG?8?L.W8VWR\8S][.[\<>U<W1
M1[*'8/:2[G7Z1XQC37-)U#5(MO\ 9D @1K2+<\Z 8"/N<*!@GD#/L>W-ZIJ$
MNJZK=W\W^LN)6D(STR>GX=*J44U!)\R_KJ+F=K!1115DA1110 4444 %>[?!
M7_D3KS_L(/\ ^BXZ\)KW;X*_\B=>?]A!_P#T7'7+B_X1T8?XST>BBBO(/1"J
MVHJSZ9=HBEF:%P !DD[35FBIDN9-=RHOE:?8\U_LO4/^?&Y_[\M_A1_9>H?\
M^-S_ -^6_P *]*HKR/[)A_,_P/6_M:?\J_$\U_LO4/\ GQN?^_+?X4?V7J'_
M #XW/_?EO\*]*HH_LF'\S_ /[6G_ "K\3S7^R]0_Y\;G_ORW^%']EZA_SXW/
M_?EO\*]*HH_LF'\S_ /[6G_*OQ/+[K0)[Z P7>DR7$)()CEMBZG'L13+?PVU
MI;-;6VBF&!L[HH[7:ISUR ,5ZG15?V5&UN=B_M25[\B/*1X6 LA9#00+0'/D
M?8_DSG.=N,=:>OAR1+I[I=&9;B1=KRBUP[#T)QDBO4Z*/[+C_.Q?VI+^1'EJ
M>'98U@5-'=5M_P#4@6I CXQ\O''''%(GAMX_+V:*R^6&";;7&T-][''&>_K7
MJ=%']EQ_G8_[4E_(CRH>&-J,@T+"-$(2HM.#'_<Z?=]NE$OA<3LK3:%YC*GE
MJ7M,D+Z#(Z>U>JT4?V7'^=B_M-[<B/*V\,EYVG;1"TS,K-(;3+$K]TDXSD=O
M2G#P[(+PW@T9A=%=IG%K\Y'INQG%>I44?V7'^=C_ +4E_(CRR/PV\/D^5HK)
MY&XQ;;7'E[NNWCC/?%1WGA5=1=7OM %TZC"M/9[R!Z#(KU>BC^RXWOSL7]J2
MM;D1Y9-X<>Y6)9]%:58CF,/:[@AZ<9'% \-L&@8:*0T"E(2+7F-2,87C@8["
MO4Z*/[+C_.P_M27\B/+K7P]+8QF.TT=[="=Q6&V* GUP!UJ?^R]0_P"?&Y_[
M\M_A7I5%)Y5!ZN;_  &LUFM%!?B>:_V7J'_/C<_]^6_PH_LO4/\ GQN?^_+?
MX5Z512_LF'\S_ ?]K3_E7XGFO]EZA_SXW/\ WY;_  H_LO4/^?&Y_P"_+?X5
MZ511_9,/YG^ ?VM/^5?B</X?L+R'6[>26TGC0;LLT9 'RGO76:HC2:=*J*68
MXP%&3U%7**[J&%5&FZ:=[G!B<0\1+F:L<C]CNO\ GVF_[X-'V.Z_Y]IO^^#7
M744?58]SDY3D?L=U_P ^TW_?!H^QW7_/M-_WP:ZZBCZK'N'*<C]CNO\ GVF_
M[X-'V.Z_Y]IO^^#7744?58]PY3D?L=U_S[3?]\&C['=?\^TW_?!KKJ*/JL>X
M<IR/V.Z_Y]IO^^#1]CNO^?:;_O@UUU%'U6/<.4Y'['=?\^TW_?!H^QW7_/M-
M_P!\&NNHH^JQ[ARG(_8[K_GVF_[X-'V.Z_Y]IO\ O@UUU%'U6/<.4Y'['=?\
M^TW_ 'P:/L=U_P ^TW_?!KKJ*/JL>X<IR/V.Z_Y]IO\ O@T?8[K_ )]IO^^#
M7744?58]PY3D?L=U_P ^TW_?!H^QW7_/M-_WP:ZZBCZK'N'*<C]CNO\ GVF_
M[X-'V.Z_Y]IO^^#7744?58]PY3D?L=U_S[3?]\&C['=?\^TW_?!KKJ*/JL>X
M<IR/V.Z_Y]IO^^#1]CNO^?:;_O@UUU%'U6/<.4Y'['=?\^TW_?!H^QW7_/M-
M_P!\&NNHH^JQ[ARG(_8[K_GVF_[X-'V.Z_Y]IO\ O@UUU%'U6/<.4Y'['=?\
M^TW_ 'P:/L=U_P ^TW_?!KKJ*/JL>X<IR/V.Z_Y]IO\ O@T?8[K_ )]IO^^#
M7744?58]PY3D?L=U_P ^TW_?!H^QW7_/M-_WP:ZZBCZK'N'*<C]CNO\ GVF_
M[X-'V.Z_Y]IO^^#7744?58]PY3D?L=U_S[3?]\&C['=?\^TW_?!KKJ*/JL>X
M<IR/V.Z_Y]IO^^#6OH<,L/G^9&Z9VXW*1GK6O150PZA+FN"5CEOB/:7-]X"U
M.VM+>6XG?RML4*%V;$J$X Y/ )KP/_A$_$?_ $+^J_\ @')_A7U(S*@RS #W
M--\Z+_GJG_?0KTJ.(E3C9(RJ45-W;/EW_A$_$?\ T+^J_P#@')_A1_PB?B/_
M *%_5?\ P#D_PKZB\Z+_ )ZI_P!]"CSHO^>J?]]"MOKDOY3/ZM'N?+O_  B?
MB/\ Z%_5?_ .3_"C_A$_$?\ T+^J_P#@')_A7U%YT7_/5/\ OH4>=%_SU3_O
MH4?7)?RA]6CW/EW_ (1/Q'_T+^J_^ <G^%'_  B?B/\ Z%_5?_ .3_"OJ+SH
MO^>J?]]"CSHO^>J?]]"CZY+^4/JT>Y\N_P#")^(_^A?U7_P#D_PH_P"$3\1_
M]"_JO_@')_A7U%YT7_/5/^^A1YT7_/5/^^A1]<E_*'U:/<^7?^$3\1_]"_JO
M_@')_A1_PB?B/_H7]5_\ Y/\*^HO.B_YZI_WT*/.B_YZI_WT*/KDOY0^K1[G
MR[_PB?B/_H7]5_\  .3_  H_X1/Q'_T+^J_^ <G^%?47G1?\]4_[Z%'G1?\
M/5/^^A1]<E_*'U:/<^7?^$3\1_\ 0OZK_P" <G^%'_")^(_^A?U7_P  Y/\
M"OJ+SHO^>J?]]"CSHO\ GJG_ 'T*/KDOY0^K1[GR[_PB?B/_ *%_5?\ P#D_
MPH_X1/Q'_P!"_JO_ (!R?X5]1>=%_P ]4_[Z%'G1?\]4_P"^A1]<E_*'U:/<
M^7?^$3\1_P#0OZK_ . <G^%'_")^(_\ H7]5_P# .3_"OJ+SHO\ GJG_ 'T*
M/.B_YZI_WT*/KDOY0^K1[GR[_P (GXC_ .A?U7_P#D_PH_X1/Q'_ -"_JO\
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M<B6[V"W,$BHX!$;;^6R.!GC.*;H7C#4=6AT]+'2'O5^QVL][/+=HDB><,C:
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M\_\ UZ/[<N_2/_OG_P"O6;17F>UGW(NS2_MR[](_^^?_ *]']N7?I'_WS_\
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M][^AK.K1O_\ 4+_O?T-9U;0V,Y;A1115$A1110 4444 %%%% !1110 4444
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MP'_T(5=JEJ__ ""YO^ _^A"HJ? Q/8Y>BBBO(,PHHHH **** "BBB@ HHHH
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M^&Y/(/\ =[5HW?A&>1YHK/4DMK*>>"XFA-L&8O'LQM8, JD1J"-OTQTJNO\
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M$/A::+6+6Y;4O,M+29IH(FA_>IN4KY?F[O\ 5C)PNT=N<#%6]2TJ:XUB.ZA
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M!=#3HHHI %%%% !6C8?ZAO\ >_H*SJT;#_4-_O?T%3/8J.Y:HHHK$T"BBB@
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M59=PY3E**ZO^S;/_ )]TH_LVS_Y]TH^JR[ARG*45U?\ 9MG_ ,^Z4?V;9_\
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MY_S'^%30PK"A522"<\U,I)H:33)****S+"BBB@ HHHH **** "BBB@ HHHH
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MT,?2K2Y5H_,YZ^ JT8\SU7D:]%%%=YPA1110 4A8*,L0!ZFEJEJ__(+F_P"
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MJ[5+5_\ D%S?\!_]"%14^!B>QR]%%%>09A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %:NEZIY!$$Y_=?PL?X?_ *U95%7";@[H$[':@Y&1THKGM,U0P8AG),79
MO[O_ -:N@!! (.0>A%>G3J*:NC1.XM%%%:#*M_\ ZA?][^AK.K1O_P#4+_O?
MT-9U;0V,Y;A7-:[I6KWGB?2KW3)XK9;>WN$DFEB$J@N8\ IN4G.TG(/!'/H>
MEHJA)V.9@\'QVUEJ%K'>N5O-/6S+O&"P(\S+G!&23(3CCI3H_">RVN8?MN?/
MU&"^SY73R_+^7KW\OKVSTXJY+XIT>'5'TZ2Z<7,<BQ2?N)"D;L 5#/MVKG<,
M9/)X'-.3Q-I$EW+;+=DO%ORWE/L8I]\*^-K%<'(4DC%%[:_UH#3V_KL9G_")
MWG]E7VD#60--FBFC@A%J-T?F$GYFW?,%R< !>.N:KV'A?4I+J]%]>"+3VU-K
MR.W6(%W((*-Y@;A<@':5SD=<<5-_PG5C/K5G8V<$[P3PO<27=Q!-#&D2X^92
MT>&'/7(7WR0#?'B_1#;RSF[D18F165[:57.\[4(0KN8,> 0"#ZTK!N8D7P_E
M$K2SZK%+,;&>Q\T6A$CI(!AG8N2S C/8')P!G-;VL:)<:CIUI;VU\L#V[JQ\
MR-GCE 4KAU5U)'.?O=0.M1?\)GH0G\EKF=) XC(DM)DVN5#!#E!AR",*>3T
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MD?+D_6N4TW4_$%R_AE_[2B>>YM+N5R\;^6V-N-R!QN(Y[C&?S7([M/I_P?\
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M^82I6?[#-:K(#G@)+SD8YY(Y'TI.#2N3YFY1114 %:>F:F;<B&8YB/0_W?\
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MJ^%Y-;L9O,27B9U0NI!5B@.TL,#DC...E:E%',[WN!FVV@:9:7C74-N1*=V
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M^)H]>U/5K2*V>)+!XU#R!E:3>@;E&4%".F#1O="3M9]OZ_0P[WP[<6EMK!O
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M\4D7B[3UM3->;X7-Q/"L44;SL5BD*%R$4D+P"21@9ZTT^O\ 785G:W]=SF-
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M [XJ*/Q=:R:G=V9B>+[+>"U9YDD4/F(R94[,$\'C/3G/(R]E;^NG^0[MN_\
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M** "BBB@ HHHH *L6=G)>3;$& /O-V HL[.2\FV(, ?>;L!746UM':PB.,8
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M?<</_P (EJ/]Z#_OL_X4?\(EJ/\ >@_[[/\ A7<44?V90\_O#^TZ_E]QP_\
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M*/[!@_YZR?I6K11[&GV"R(K:VCM81'$, =3W)]34M%%:))*R&%%%%, HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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JW/U-'V.#^Y^IJ>BB["R(/L<']S]34D<:1+M08&<]:?11=A8****0S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  A ) # 2(  A$! Q$!_\0
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M20DMC.=QQCWZ51TR_N[?P4;-<F6]N#!:@\?*< D>V<_G761^!-"CD#FT+8/
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6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
